• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C型HIV中K65R和K65R/M184V逆转录酶突变对酶功能和耐药性的影响。

Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance.

作者信息

Xu Hong-Tao, Martinez-Cajas Jorge L, Ntemgwa Michel L, Coutsinos Dimitrios, Frankel Fernando A, Brenner Bluma G, Wainberg Mark A

机构信息

McGill University AIDS Centre, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec H3T1E2, Canada.

出版信息

Retrovirology. 2009 Feb 11;6:14. doi: 10.1186/1742-4690-6-14.

DOI:10.1186/1742-4690-6-14
PMID:19210791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2644664/
Abstract

BACKGROUND

We investigated the effects of mutations K65R and K65R plus M184V on enzymatic function and mechanisms of drug resistance in subtype C reverse transcriptase (RT).

METHODS

Recombinant subtype C HIV-1 RTs containing K65R or K65R+M184V were purified from Escherichia coli. Enzyme activities and tenofovir (TFV) incorporation efficiency by wild-type (WT) and mutant RTs of both subtypes were determined in cell-free assays. Efficiency of (-) ssDNA synthesis and initiation by subtype C RTs was measured using gel-based assays with HIV-1 PBS RNA template and tRNA3Lys as primer. Single-cycle processivity was assayed under variable dNTP concentrations. Steady-state analysis was performed to measure the relative inhibitory capacity (ki/km) of TFV-disphosphate (TFV-DP). ATP-dependent excision and rescue of TFV-or ZDV-terminated DNA synthesis was monitored in time-course experiments.

RESULTS

The efficiency of tRNA-primed (-)ssDNA synthesis by subtype C RTs was: WT > K65R > K65R+M184V RT. At low dNTP concentration, K65R RT exhibited lower activity in single-cycle processivity assays while the K65R+M184V mutant showed diminished processivity independent of dNTP concentration. ATP-mediated excision of TFV-or ZDV-terminated primer was decreased for K65R and for K65R+M184V RT compared to WT RT. K65R and K65R+M184V displayed 9.8-and 5-fold increases in IC50 for TFV-DP compared to WT RT. The Ki/Km of TFV was increased by 4.1-and 7.2-fold, respectively, for K65R and K65R+M184V compared to WT RT.

CONCLUSION

The diminished initiation efficiency of K65R-containing RTs at low dNTP concentrations have been confirmed for subtype C as well as subtype B. Despite decreased excision, this decreased binding/incorporation results in diminished susceptibility of K65R and K65R+M184 RT to TFV-DP.

摘要

背景

我们研究了K65R突变以及K65R加M184V突变对C亚型逆转录酶(RT)酶功能及耐药机制的影响。

方法

从大肠杆菌中纯化出含有K65R或K65R + M184V的重组C亚型HIV-1 RT。在无细胞试验中测定野生型(WT)和两种亚型突变RT的酶活性及替诺福韦(TFV)掺入效率。使用以HIV-1 PBS RNA为模板、tRNA3Lys为引物的基于凝胶的试验,测量C亚型RT的(-)单链DNA合成及起始效率。在不同的脱氧核苷三磷酸(dNTP)浓度下测定单轮持续合成能力。进行稳态分析以测量二磷酸替诺福韦(TFV-DP)的相对抑制能力(ki/km)。在时间进程实验中监测ATP依赖的TFV或齐多夫定(ZDV)终止的DNA合成的切除及挽救情况。

结果

C亚型RT以tRNA为引物的(-)单链DNA合成效率为:WT > K65R > K65R + M184V RT。在低dNTP浓度下,K65R RT在单轮持续合成能力试验中表现出较低活性,而K65R + M184V突变体显示出与dNTP浓度无关的持续合成能力降低。与WT RT相比,K65R和K65R + M184V RT的ATP介导的TFV或ZDV终止引物的切除减少。与WT RT相比,K65R和K65R + M184V对TFV-DP的半数抑制浓度(IC50)分别增加了9.8倍和5倍。与WT RT相比,K65R和K65R + M184V的TFV的Ki/Km分别增加了4.1倍和7.2倍。

结论

对于C亚型以及B亚型,已证实含K65R的RT在低dNTP浓度下起始效率降低。尽管切除减少,但这种结合/掺入的降低导致K65R和K65R + M184 RT对TFV-DP敏感性降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/2644664/0f82b66c11a5/1742-4690-6-14-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/2644664/a13e6fe88dee/1742-4690-6-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/2644664/642f0b559d01/1742-4690-6-14-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/2644664/8daaa405cacf/1742-4690-6-14-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/2644664/0f82b66c11a5/1742-4690-6-14-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/2644664/a13e6fe88dee/1742-4690-6-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/2644664/642f0b559d01/1742-4690-6-14-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/2644664/8daaa405cacf/1742-4690-6-14-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be27/2644664/0f82b66c11a5/1742-4690-6-14-4.jpg

相似文献

1
Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance.C型HIV中K65R和K65R/M184V逆转录酶突变对酶功能和耐药性的影响。
Retrovirology. 2009 Feb 11;6:14. doi: 10.1186/1742-4690-6-14.
2
The balance between NRTI discrimination and excision drives the susceptibility of HIV-1 RT mutants K65R, M184V and K65r+M184V.核苷类逆转录酶抑制剂(NRTI)识别与切除之间的平衡决定了HIV-1逆转录酶突变体K65R、M184V和K65R+M184V的易感性。
Antivir Chem Chemother. 2007;18(6):307-16. doi: 10.1177/095632020701800603.
3
Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity.具有逆转录酶突变K65R和K65R+M184V的1型人类免疫缺陷病毒耐药性的分子机制及其对酶功能和病毒复制能力的影响。
Antimicrob Agents Chemother. 2002 Nov;46(11):3437-46. doi: 10.1128/AAC.46.11.3437-3446.2002.
4
Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance.HIV-1 逆转录酶聚合、切除拮抗和替诺福韦耐药中 K65R 突变作用的结构基础。
J Biol Chem. 2009 Dec 11;284(50):35092-100. doi: 10.1074/jbc.M109.022525. Epub 2009 Oct 7.
5
Effects of the W153L substitution in HIV reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitors.HIV逆转录酶中W153L替换对病毒复制及对多类逆转录酶抑制剂耐药性的影响。
Antimicrob Agents Chemother. 2014 Aug;58(8):4515-26. doi: 10.1128/AAC.02729-14. Epub 2014 May 27.
6
Drug Susceptibility and Viral Fitness of HIV-1 with Integrase Strand Transfer Inhibitor Resistance Substitution Q148R or N155H in Combination with Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Resistance Substitutions.具有整合酶链转移抑制剂耐药性替代Q148R或N155H并与核苷/核苷酸逆转录酶抑制剂耐药性替代联合存在的HIV-1的药物敏感性和病毒适应性
Antimicrob Agents Chemother. 2015 Nov 16;60(2):757-65. doi: 10.1128/AAC.02096-15. Print 2016 Feb.
7
A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virus.在 K65R 突变背景下,HIV-1 逆转录酶密码子 74 处由亮氨酸变为异亮氨酸而不是亮氨酸变为缬氨酸,可导致 K65R+L74I 酶的延伸性增加和具有复制能力的病毒。
Virol J. 2011 Jan 21;8:33. doi: 10.1186/1743-422X-8-33.
8
Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tract.理解 HIV-1 逆转录酶序列依赖性替诺福韦去除的分子机制:引物结合位点与多聚嘧啶区的差异。
Antiviral Res. 2012 Aug;95(2):93-103. doi: 10.1016/j.antiviral.2012.05.012. Epub 2012 Jun 1.
9
Fidelity of classwide-resistant HIV-2 reverse transcriptase and differential contribution of K65R to the accuracy of HIV-1 and HIV-2 reverse transcriptases.广谱耐药 HIV-2 逆转录酶的保真度和 K65R 对 HIV-1 和 HIV-2 逆转录酶准确性的差异贡献。
Sci Rep. 2017 Mar 23;7:44834. doi: 10.1038/srep44834.
10
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.临床、病毒学和生物化学证据支持 HIV-1 逆转录酶多态性 R284K 与替诺福韦/恩曲他滨治疗失败患者中胸苷类似物耐药突变 M41L、L210W 和 T215Y 的关联。
Retrovirology. 2012 Aug 13;9:68. doi: 10.1186/1742-4690-9-68.

引用本文的文献

1
Consensus Sequences for and Introduced into HIV-1 Clade B Laboratory Strains Differentially Influence the Impact of Point Mutations Associated with Immune Escape and with Drug Resistance on Viral Replicative Capacity.引入HIV-1 B亚型实验室毒株的[具体内容]和[具体内容]的共有序列对与免疫逃逸及耐药相关的点突变对病毒复制能力的影响产生不同作用。
Viruses. 2025 Jun 12;17(6):842. doi: 10.3390/v17060842.
2
Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation.初治和经治 HIV-1 感染者携带 M184V 突变的治疗管理挑战。
Viruses. 2024 Aug 30;16(9):1392. doi: 10.3390/v16091392.
3

本文引用的文献

1
Human immunodeficiency virus type-1 reverse transcriptase exists as post-translationally modified forms in virions and cells.1型人类免疫缺陷病毒逆转录酶在病毒粒子和细胞中以翻译后修饰形式存在。
Retrovirology. 2008 Dec 18;5:115. doi: 10.1186/1742-4690-5-115.
2
Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1.模板使用情况导致在1型人类免疫缺陷病毒C亚型变体中优先获得K65R逆转录酶突变。
J Virol. 2009 Feb;83(4):2029-33. doi: 10.1128/JVI.01349-08. Epub 2008 Dec 10.
3
The challenge of HIV-1 subtype diversity.
HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014-2019.
2014 - 2019年华南男男性行为者抗逆转录病毒治疗失败人群中的HIV-1耐药性与基因传播网络
Infect Drug Resist. 2021 Aug 4;14:2977-2989. doi: 10.2147/IDR.S317187. eCollection 2021.
4
Precise and Programmable Detection of Mutations Using Ultraspecific Riboregulators.利用超特异核糖调控因子精确且可编程地检测突变。
Cell. 2020 Mar 5;180(5):1018-1032.e16. doi: 10.1016/j.cell.2020.02.011. Epub 2020 Feb 27.
5
HIV-1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROS-Dependent Upregulation of Twist.HIV-1 逆转录酶通过 ROS 依赖性上调 Twist 促进肿瘤生长和转移形成。
Oxid Med Cell Longev. 2019 Dec 2;2019:6016278. doi: 10.1155/2019/6016278. eCollection 2019.
6
Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study.南非 HIV 感染患者首选抗逆转录病毒治疗方案耐药性:一项建模研究。
PLoS One. 2019 Jul 3;14(7):e0218649. doi: 10.1371/journal.pone.0218649. eCollection 2019.
7
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study.撒哈拉以南非洲地区基于多替拉韦的抗逆转录病毒药物方案的风险和获益:一项建模研究。
Lancet HIV. 2019 Feb;6(2):e116-e127. doi: 10.1016/S2352-3018(18)30317-5. Epub 2018 Nov 29.
8
Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.拉米夫定 25 年:目前和未来用于治疗 HIV-1 感染。
J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):125-135. doi: 10.1097/QAI.0000000000001660.
9
Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors.寨卡病毒RNA依赖性RNA聚合酶的纯化及其在鉴定寨卡小分子抑制剂中的应用。
J Antimicrob Chemother. 2017 Mar 1;72(3):727-734. doi: 10.1093/jac/dkw514.
10
Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses.NRTI/NNRTI耐药病毒中DTG耐药突变对HIV-1病毒复制能力的影响。
Retrovirology. 2016 Apr 30;13(1):31. doi: 10.1186/s12977-016-0265-x.
HIV-1亚型多样性的挑战。
N Engl J Med. 2008 Oct 30;359(18):1965-6. doi: 10.1056/NEJMc086373.
4
Update of the drug resistance mutations in HIV-1: Spring 2008.2008年春季HIV-1耐药性突变的更新情况。
Top HIV Med. 2008 Apr-May;16(1):62-8. doi: 10.1007/s11750-007-0034-z.
5
The balance between NRTI discrimination and excision drives the susceptibility of HIV-1 RT mutants K65R, M184V and K65r+M184V.核苷类逆转录酶抑制剂(NRTI)识别与切除之间的平衡决定了HIV-1逆转录酶突变体K65R、M184V和K65R+M184V的易感性。
Antivir Chem Chemother. 2007;18(6):307-16. doi: 10.1177/095632020701800603.
6
Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase.HIV-1逆转录酶核苷类似物抑制剂的耐药机制。
Virus Res. 2008 Jun;134(1-2):124-46. doi: 10.1016/j.virusres.2007.12.015. Epub 2008 Feb 12.
7
The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa.逆转录酶67N 70R 215Y基因型是在非洲南部接受含齐多夫定/去羟肌苷的高效抗逆转录病毒治疗的1型HIV感染成人中与病毒学失败相关的主要TAM途径。
AIDS Res Hum Retroviruses. 2007 Jul;23(7):868-78. doi: 10.1089/aid.2006.0298.
8
Kinetics of inhibition of HIV type 1 reverse transcriptase-bearing NRTI-associated mutations by apricitabine triphosphate.
Antivir Chem Chemother. 2007;18(2):93-101. doi: 10.1177/095632020701800205.
9
Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir.1型人类免疫缺陷病毒逆转录酶的易位状态对替诺福韦切除效率的影响
Antimicrob Agents Chemother. 2007 Aug;51(8):2911-9. doi: 10.1128/AAC.00314-07. Epub 2007 May 21.
10
Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.在慢性RT-SHIV感染的恒河猴长期接受替诺福韦单药治疗期间,逆转录酶中具有K70E和K65R突变的病毒突变体的相继出现及其临床意义。
Retrovirology. 2007 Apr 6;4:25. doi: 10.1186/1742-4690-4-25.